Latest Blogs

May 20, 2019
Dr. Ward and I discuss the policies that public and private insurers use to control the use of anticancer drug therapies, such as prior authorization requirements, restrictive formularies, step therapy, or fail first requirements, and specialty specific tiers.
May 17, 2019
To help you get the most out of #ASCO19, I'm sharing a vlog on networking (it's not as scary as you think!) and strategies for organizing your schedule and maximizing your face time with the people you want to meet.
May 16, 2019
My patient had struggled emotionally throughout the course of her cancer treatment, until the day I walked into the room and noticed a profound change.
May 16, 2019
"As women in oncology, we have so many common stories and so much to learn from one another," writes Dr. Jane Lowe Meisel.
Subscribe to this column

John Vernon Cox, DO, FASCO

John V. Cox, DO, FACP, FASCO, MBA, recently joined the University of Texas Southwestern Medical Center/Parkland Health System. He is Editor-in-Chief of the Journal of Oncology Practice, Immediate Past Chair of ASCO's Cancer Education Committee, and serves on the Leadership Development Working Group and Ethics Committee. Dr. Cox is interested in new models/structures of care delivery.

Jan 15, 2013
The Journal of Oncology Practice (JOP) is in its eighth year of publication and has remained focused on presenting data-oriented articles highlighting issues related to the mechanisms of oncology care delivery.
Jul 28, 2011
You just received your July issue of JOP. This is the Journal's first thematic issue addressing electronic health records (EHRs). It is long overdue. Three manuscripts in the issue set up the legislative and regulatory underpinning related to the topic....
Apr 06, 2011
What is old, is new again. Off-label use of oncology drugs is common; and has long been the focus of controversy. Payers are often confused by the broad use of a therapeutic across seemingly unrelated diagnoses. They look to the FDA label for guidance on the specific use of a drug. Yet the FDA-...
Sep 11, 2010
Modern business principles have convinced jillions of us that the road to quality improvement lies in managing processes within our practice/business. Certainly medicine and policy makers have taken this to heart, developing multiple ‘measures’ that focus on the processes of care. CMS’s PQRI...
Jun 30, 2010
As I highlighted in the May editor’s desk column -- a colleague noted that in traveling the country, she had found oncologists often voiced feelings of being victimized by the ‘system’. They were tired, overburdened by the moment, and struggling with market forces in their locales, whether...
Apr 16, 2010
I ran across a post on a healthcare blog that I would encourage folk to read. Jann Sidorov writes about the predicted death of small practices. I love his analogy to an...

Pages